Relevance of Placental protein 13 in combination with Xanthine oxidase activity andAsymmetric dimethylargininein early prediction of Preeclampsia with an evidence of LGALS13 gene promoter variant

Authors

  • Ranjeeta Gadde
  • C.D. Dayanand
  • B Sharath
  • S.R. Sheela

DOI:

https://doi.org/10.51248/.v41i2.1053

Keywords:

Placental protein 13, LGALS13, xanthine oxidase activity, asymmetric dimethylarginine

Abstract

Introduction and Aim:Preeclampsia is a pregnancy specific hypertensive disorder and its complications are associated with maternal morbidity and mortality. The intention of the study is to determine early placental and endothelial dysfunction markers in first and second trimesters of pregnancy for the prediction of preeclampsia.

Materials and Methods:Study design was prospective which enrolled 268 pregnant women during their first ante-natal visit. Blood samples were analysed for Placental protein13 (PP13), Asymmetric dimethyl arginine (ADMA) by ELISA and Xanthine oxidase (XO) activity by colorimetric assay. On follow-up, 22 subjects developed preeclampsia, 12 had spontaneous abortions and the rest remained normotensive till delivery. PP13 gene, LGALS13 was sequenced in preeclampsia cases to know if any polymorphism was present.

Results:Results were analysed by Wilcoxon Signed Ranks test know the level of statistical significance, correlation analysis by Spearman’s correlation and diagnostic performance of the measured parameters was assessed by receivers operating characteristic (ROC) curve. Pregnant women who developed Preeclampsia had low PP13 levels in first trimester and elevated ADMA in second trimester (p<0.001). Gene sequencing of LGALS13 in preeclampsia showed -98C/A SNP at promoter region. ROC curve showed AUC for first trimester PP13 (0.932), second trimester PP13 (0.955) second trimester XO activity (0.967) and second trimester ADMA (1.000).

Conclusion: The results suggest that oxidative stress, placental and endothelial dysfunction biomarkers would be helpful for early prediction of preeclampsia.

Author Biographies

Ranjeeta Gadde

Sri Devaraj Urs Medical College& Hospital, Sri Devaraj Urs Academy of Higher Education and Research, Tamaka, Kolar, Karnataka, India

C.D. Dayanand

Sri DevarajUrs Medical College& Hospital, Sri Devaraj Urs Academy of Higher Education and Research, Tamaka, Kolar, Karnataka, India

B Sharath

Sri DevarajUrs Medical College& Hospital, Sri Devaraj Urs Academy of Higher Education and Research, Tamaka, Kolar, Karnataka, India

S.R. Sheela

Sri DevarajUrs Medical College& Hospital, Sri Devaraj Urs Academy of Higher Education and Research, Tamaka, Kolar, Karnataka, India

References

Gyselaers,W. Preeclampsia Is a Syndrome with a Cascade of Pathophysiologic Events. J Clin Med. 2020;9(7):2245. doi: 10.3390/jcm9072245. PMID: 32679789.

Pacheco-Romero, J., Acosta, O., Huerta, D., Cabrera, S., Vargas, M., Mascaro, P., etal., Genetic markers for preeclampsia in Peruvian women. Colomb Med (Cali). 2021 ;52(1):e2014437. doi: 10.25100/cm.v52i1.4437. PMID: 33911318.

Beardmore-Gray, A., Vousden, N., Silverio,S.A., Charantimath, U., Katageri, G., Bellad, M.,etal., Planned early delivery for late preterm pre-eclampsia in a low-and middle-income setting: a feasibility study. Reprod Health. 2021;18:110. doi.org/10.1186/s12978-021-01159-y.

Yang, T., Yao, Y., Wang, X., Li, Y., Si, Y., Li, X., etal., Galectin-13/placental protein 13: redox-active disulfides as switches for regulating structure, function and cellular distribution. Glycobiology. 2020;30(2):120-129. doi: 10.1093/glycob/cwz081. PMID: 31584064.

Li, X., Yao, Y., Liu, T., Gu, K., Han, Q., Zhang, W.,etal.,Actin binding to galectin-13/placental protein-13 occurs independently of the galectin canonical ligand binding site. Glycobiology. 2021;cwab047. doi: 10.1093/glycob/cwab047. PMID: 34080003.

Drobnjak,T., Jónsdóttir, A.M., Helgadóttir, H., Runólfsdóttir, M.S., Meiri, H., Sammar, M.,etal., Placental protein 13 (PP13) stimulates rat uterine vessels after slow subcutaneous administration. Int J Womens Health. 2019;11:213-222. doi: 10.2147/IJWH.S188303. PMID: 30988643.

Das N.S., Dheen, S.T., Ling, E.A., Bay, B.H., Srinivasan, D.K. Therapeutic Prospects in Preeclampsia - A Mini-Review. Curr Med Chem. 2019;26(25):4786-4798. doi: 10.2174/0929867326666190228115423. PMID: 30836908.

Vokalova, L., Balogh, A., Toth, E., Van Breda, S.V., Schäfer, G., Hoesli, I., et al., Placental Protein 13 (Galectin-13) polarizes neutrophils toward an immune regulatory phenotype. Front Immunol. 2020;11:145.doi: 10.3389/fimmu.2020.00145. PMID: 32117288.

San Juan-Reyes, S., Gómez-Oliván, L.M., Islas-Flores, H., Dublán-García, O. Oxidative stress in pregnancy complicated by preeclampsia. Arch BiochemBiophys. 2020;681:108255. doi: 10.1016/j.abb.2020.108255. PMID: 31904364.

Tashie, W., Fondjo, L.A., Owiredu, W.K.B.A., Ephraim, R.K.D., Asare, L., Adu-Gyamfi, E.A.,etal. Altered Bioavailability of Nitric Oxide and L-Arginine Is a Key Determinant of Endothelial Dysfunction in Preeclampsia. Biomed Res Int. 2020;2020:3251956. doi: 10.1155/2020/3251956. PMID: 33145345.

Reddy, M., Fenn, S., Rolnik, D.L., Mol, B.W., da Silva Costa, F., Wallace, E.M.,et al.,The impact of the definition of preeclampsia on disease diagnosis and outcomes: a retrospective cohort study. Am J Obstet Gynecol. 2021;224(2):217.e1-217.e11.doi: 10.1016/j.ajog.2020.08.019. PMID: 32795430.

Soongsatitanon, A., Phupong, V. Prediction of preeclampsia using first trimester placental protein 13 and uterine artery Doppler. J MaternFetal Neonatal Med. 2020;1-6. doi: 10.1080/14767058.2020.1849127. PMID: 33198548.

Antwi, E., Amoakoh-Coleman, M., Vieira, D.L., Madhavaram, S., Koram, K.A., Grobbee, D.E.,et al.,Systematic review of prediction models for gestational hypertension and preeclampsia. PLoSONE. 2020;15(4):e0230955.

Sunjaya, A. F., Sunjaya, A. P., Evaluation of serum biomarkers and other diagnostic modalities for early diagnosis of preeclampsia. J Family Reprod Health. 2019;13(2):56-69. PMID: 31988641.

Asiltas, B., Surmen-Gur, E., Uncu, G. Prediction of first-trimester preeclampsia: Relevance of the oxidative stress marker MDA in a combination model with PP- 13, PAPP-A and beta-HCG. Pathophysiology. 2018;25(2):131-135

Ceylan, N., Ozaksit, G., Unlu, B.S., Yildiz, Y., Yilmaz, S., Agaca, F. Can first trimester placental protein-13 and pregnancy-associated plasma protein-A predict preeclampsia in Turkish women? J ObstetGynaecol. 2014;34(6):482-485.

Seravalli, V., Grimpel, Y.I., Meiri, H., Blitzer, H., Baschat, A.A. Relationship between first-trimester serum placental protein-13 and maternal characteristics, placental Doppler studies and pregnancy outcome. J Perinat Med. 2016;44(5):543-549.

Ryu, A., Cho, N.J., Kim, Y.S., Lee, E.Y. Predictive value of serum uric acid levels for adverse perinatal outcomes in preeclampsia. Medicine (Baltimore). 2019;98(18):e15462. doi: 10.1097/MD.0000000000015462. PMID: 31045822.

Guerby, P., Tasta, O., Swiader, A., Pont, F., Bujold, E., Parant, O.,et al.,Role of oxidative stress in the dysfunction of the placental endothelial nitric oxide synthase in preeclampsia. Redox Biol. 2021;40:101861. doi: 10.1016/j.redox.2021.101861. PMID: 33548859.

Jarquin Campos, A., Risch, L., Baumann, M., Purde, M.T., Neuber, S., Renz, H.,et al., Shrunken pore syndrome, preeclampsia, and markers of NO metabolism in pregnant women during the first trimester. Scand J Clin Lab Invest. 2019;79(1-2):91-98. doi: 10.1080/00365513.2019.1568150. PMID: 30785340.

Selanno, J.F., Riu, D.S., Tessy, T., Chalid, M.T., Pelupessy, N.U., Hartono, E. Maternal serum levels of asymmetric dimethylarginine in normal and preeclamptic pregnancies. Gynecol Endocrinol. 2020;36(8):702-704. doi: 10.1080/09513590.2019.1707793. PMID: 32129698.

Osmanagaoglu, M.A., KarnerKarahan, S., Aran, T., Guven, S., Kart, C., Pekgoz, I., et al.,Predictive value of plasma total carnitine, arginine, asymmetric dimethyl arginine and Ischemia modified albumin levels and their combined use in the early detection of preeclampsia. Geburtshilfe und Frauenheilkunde. 2011;71:773-778.

Gebhardt, S., Bruiners, N., Hillermann, R. A novel exonic variant (221 delT) in the LGALS13 gene encoding placental protein 13 (PP 13) is associated with preterm labour in a low-risk population. Journal of Reproductive Immunology. 2009; 82(2):166-173.

Madar- Shapiro, L., Karady, I., Trahtenherts, A., Syngelaki, A., Akolekar, R., Poon, L.,et al.,Predicting the Risk to Develop Preeclampsia in the First Trimester Combining Promoter Variant -98A/C of LGALS13 (Placental Protein 13), Black Ethnicity, Previous Preeclampsia, Obesity, and Maternal Age. Fetal Diagn Ther.2017;43(4):250-265.

Downloads

Published

2021-09-07

How to Cite

1.
Gadde R, Dayanand C, Sharath B, Sheela S. Relevance of Placental protein 13 in combination with Xanthine oxidase activity andAsymmetric dimethylargininein early prediction of Preeclampsia with an evidence of LGALS13 gene promoter variant. Biomedicine [Internet]. 2021Sep.7 [cited 2021Sep.22];41(2):431-8. Available from: https://biomedicineonline.org/index.php/home/article/view/1053